BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2473642)

  • 1. Effects of antihistamines on isolated human lung mast cells, basophil leucocytes and erythrocytes.
    Lau HY; Pearce FL
    Agents Actions; 1989 Apr; 27(1-2):83-5. PubMed ID: 2473642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antihistamines on isolated rat peritoneal mast cells and on model membrane systems.
    Lau HY; Pearce FL
    Agents Actions; 1990 Mar; 29(3-4):151-61. PubMed ID: 1692660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells.
    Marone G; Columbo M; de Paulis A; Cirillo R; Giugliano R; Condorelli M
    Agents Actions; 1986 Apr; 18(1-2):103-6. PubMed ID: 2425567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effect of antihistamines on rat peritoneal mast cells: induction and inhibition of histamine release.
    Lau HY; Pearce FL
    Agents Actions; 1985 Apr; 16(3-4):176-8. PubMed ID: 2409770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihistamines on isolated mast cells from the rat, guinea pig and man.
    Lau HY; Pearce FL
    Agents Actions; 1986 Apr; 18(1-2):107-9. PubMed ID: 2425568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of olopatadine and selected antihistamines with model and natural membranes.
    Brockman HL; Momsen MM; Knudtson JR; Miller ST; Graff G; Yanni JM
    Ocul Immunol Inflamm; 2003 Dec; 11(4):247-68. PubMed ID: 14704897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Aug; 69(4):663-7. PubMed ID: 6159940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
    Okayama Y; Benyon RC; Lowman MA; Church MK
    Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists.
    Lippert U; Möller A; Welker P; Artuc M; Henz BM
    Exp Dermatol; 2000 Apr; 9(2):118-24. PubMed ID: 10772385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A species comparison of the histamine H2-receptor on mast cells and basophils.
    Rising TJ; Lewis S
    Agents Actions; 1982 Jul; 12(3):263-7. PubMed ID: 6182771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic activity of nylidrin hydrochloride (RHC 3432-A). I. Effect on release of histamine in vitro from rat peritoneal mast cells, guinea pig lung slices and human basophils.
    Khandwala A; Coutts SM; Weinryb I
    Int Arch Allergy Appl Immunol; 1983; 70(4):295-302. PubMed ID: 6186608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forskolin inhibits the release of histamine from human basophils and mast cells.
    Marone G; Columbo M; Triggiani M; Vigorita S; Formisano S
    Agents Actions; 1986 Apr; 18(1-2):96-9. PubMed ID: 2425602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin.
    Marone G; Columbo M; Galeone D; Guidi G; Kagey-Sobotka A; Lichtenstein LM
    Agents Actions; 1986 Apr; 18(1-2):100-2. PubMed ID: 2425566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The action of nicotinamide on the release of histamine.
    Parrot JL; Wyczolkowska Y; Santais MC; Ruff F; Mordelet-Dambrine M; Maśliński C
    Agents Actions; 1974 Aug; 4(3):202. PubMed ID: 4137965
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
    Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
    Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxatomide: inhibition and stimulation of histamine release from human lung and leucocytes in vitro.
    Church MK; Gradidge CF
    Agents Actions; 1980 Apr; 10(1 Pt 2):4-7. PubMed ID: 6155772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ketotifen and oxatomide on histamine secretion from mast cells.
    Truneh A; White JR; Pearce FL
    Agents Actions; 1982 Apr; 12(1-2):206-9. PubMed ID: 6177216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of recombinant stem cell factor on human skin and lung mast cells and basophil leukocytes.
    Frenz AM; Gibbs BF; Pearce FL
    Inflamm Res; 1997 Feb; 46(2):35-9. PubMed ID: 9085141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A; Coutts S; Pruss T; Jones H; Neiss E; Weinryb I
    Biochem Pharmacol; 1987 Mar; 36(5):663-72. PubMed ID: 2435293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.